🔗 Permalink

Inventor profile of:

Stephen Cusack

City:

Seyssinet-Pariset

Country:

France

Published Applications:

Last publication date:

2019-08-15

Top Assignees for applications by Stephen Cusack

The entities that hold a legal rights for patent applications filed by inventor Cusack Stephen:

European Molecular Biology Laboratory 9 Heidelberg, Germany
F. Hoffmann-La Roche AG 4 Basel, Switzerland
SAVIRA PHARMACEUTICALS GMBH 4 Vienna, Austria
Savira pharmaceuticals GmbH 2 Vienna, Australia
EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) 2 Heidelberg, Germany
F. HOFFMAN-LA ROCHE AG 2 Basel, Switzerland
UNIVERSITY JOSEPH FOURIER FILIALE 1 Gieres, France
Centre National de la Recherche Scientifique - Direction de la Politique Industrielle 1 ParisCedex, France
UNIVERSITE GRENOBLE ALPES 1 Saint-Martin-d'Hères, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France

Recent patent applications by Cusack Stephen

Stephen Cusack from Seyssinet-Pariset, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-15

US20190252037A1

Physics

Viral Polypeptide Fragments That Bind Cellular POL II C-Terminal Domain (CTD) and Their Uses

#2 | 2018-02-15

US20180044649A1

Chemistry; metallurgy

INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE

#3 | 2018-01-11

US20180010109A1

Chemistry; metallurgy

POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE

#4 | 2017-10-12

US20170290834A1

Human necessities

Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease

#5 | 2017-04-13

US20170100396A1

Human necessities

PYRROLOPYRAZINE DERIVATIVES FOR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA

#6 | 2017-03-23

US20170081331A1

Chemistry; metallurgy

Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease

#7 | 2017-03-23

US20170081324A1

Chemistry; metallurgy

Triazolones derivatives and their use in the treatment, amelioration or prevention of a viral disease

#8 | 2017-03-23

US20170081323A1

Chemistry; metallurgy

Triazolones derivatives for use in the treatment, amelioration or prevention of a viral disease

#9 | 2017-01-05

US20170000788A1

Human necessities

Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

#10 | 2016-02-25

US20160053241A1

Chemistry; metallurgy

Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use

#11 | 2016-02-11

US20160039818A1

Chemistry; metallurgy

Substituted 1,5-naphthyridines as endonuclease inhibitors

#12 | 2016-01-07

US20160002227A1

Chemistry; metallurgy

Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

#13 | 2016-01-07

US20160002226A1

Chemistry; metallurgy

PYRIDOPYRAZINE COMPOUNDS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA

#14 | 2015-04-16

US20150105315A1

Chemistry; metallurgy

Polypeptide fragments comprising endonuclease activity and their use

#15 | 2014-07-10

US20140194476A1

Chemistry; metallurgy

Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease

#16 | 2014-07-10

US20140194432A1

Chemistry; metallurgy

Substituted naphthyridines for the treatment, amelioration or prevention of a viral disease

#17 | 2014-07-10

US20140194431A1

Chemistry; metallurgy

Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease

#18 | 2013-01-24

US20130023565A1

Chemistry; metallurgy

Influenza A 2009 pandemic H1N1 polypeptide fragments comprising endonuclease activity and their use

#19 | 2012-05-03

US20120108493A1

Chemistry; metallurgy

Polypeptide Fragments Comprising Endonuclease Activity and Their Use

#20 | 2011-01-13

US20110008348A1

Human necessities

Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap

InventorID:

54873 ⎘